Shifeng Wang

Shifeng Wang

Auto-generated profile, based on publicly available information

Shifeng Wang

Tianjin Universal Medical Imaging Diagnostic Center, Tianjin 300110, P. R. China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2026 in Journal of Mechanics in Medicine and Biology
Verified
Journal Article
Open access
WZWei Zhang
Wei Zhang
XWXu Wenchao
Xu Wenchao
HYHuilan Yang
Huilan Yang
ZZZhe Zhang
Zhe Zhang
LSLong Sun
Long Sun
SWShifeng Wang
Shifeng Wang
Alzheimer’s disease (AD) is a prevalent neurodegenerative disease in aging populations. Complex network analysis helps quantify brain features for AD diagnosis, yet existing studies use coarse brain atlases and fixed thresholds, failing to capture subtle topological changes along disease progression. This study used the fine-grained Zalesky_1024 atlas to optimize thresholds and characterize topological alterations across AD progression. Resting-state functional magnetic resonance imaging (fMRI) data from cognitively normal (CN), early mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI) and AD groups were used to construct brain networks. Topological characteristics were then analyzed across thresholds to track progressive changes from CN→EMCI→LMCI→AD. Finally, support vector machine (SVM) was applied to explore the classification performance of topological characteristics. Results showed threshold-dependent topological alterations along the progression. SVM with betweenness centrality and degree achieved superior classification for EMCI versus AD and CN versus AD. Furthermore, the Zalesky_1024 template outperformed the traditional automated anatomical labeling 90 (AAL_90) template in terms of sensitivity, specificity, accuracy, and area under the curve for classification. These results reveal progressive brain topological degradation across the AD spectrum and supply imaging topological markers to advance AD staging and neuroimaging diagnostic tools.